Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. G.H. (Truuske) de Bock

Research interests

The research of Geertruida de Bock is about the early detection of cancer and improvement of outcomes after cancer treatment. To evaluate this in a systematic way, she set up an UMCG’s oncology databiobank OncoLifeS with quality of life as a main outcome. To assess and optimize screening strategies, she works on defining which populations are at risk of cancer and negative outcomes. She does not only consider benefits of screening and treatment, but also the negative effects of over-diagnosis, tumor-induction, false-positive results, and side-effects. Systematic literature reviews, analysis of cohorts and modelling are the most important methods she uses.

Publicaties

Actual physical activity after major abdominal cancer surgery: Far from optimal

Advancing Ki67 hotspot detection in breast cancer: a comparative analysis of automated digital image analysis algorithms

An Innovative Big Temporal Data Analytics Technique over Real-Life Healthcare Datasets: The F-TBDA Approach

ASO Visual Abstract: The Association between Intraoperative Compromised Intestinal Integrity and Postoperative Complications in Cancer Patients

Author Correction: Symptoms and quality of life before, during, and after a SARS-CoV-2 PCR positive or negative test: data from Lifelines (Scientific Reports, (2023), 13, 1, (11713), 10.1038/s41598-023-38223-5)

BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families

Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas

Chronic Stress Related to Cancer Incidence, including the Role of Metabolic Syndrome Components

Clinical and pathological differences between early- and late-onset colorectal cancer and determinants of one-year all-cause mortality among advanced-stage patients: a retrospective cohort study in Medellín, Colombia

Lees meer

Pers/media

Mannen krijgen vaker kankertherapie die de tumor aanpakt dan vrouwen

Mannen krijgen vaker kankertherapie die de tumor aanpakt dan vrouwen

Steeds meer mensen met kanker

Steeds meer mensen met kanker: 'Zien nu effecten van veel roken en zonnen'

UMCG krijgt vier ton subsidie voor verbetering onderzoek naar baarmoederhalskanker.

Lees meer